Osteoporosis and Fracture Risk: Causes,Cures and Preventive Strategies

Cooper C Melton LJ . Epidemiology of osteoporosis. Trends in Endocrinology and Metabolism 1992; 3: 224–229

Cooper C . Epidemiology and public health impact of osteoporosis. Baillieres Clin Rheumatol 1993; 7: 459–477

Cummings SR Kelsey JL Nevitt MC . Epidemiology of osteoporosis and osteoporotic fractures. Epidemiol Rev 1985; 7: 178–208

Cooper C Atkinson EJ Jacobsen SJ . Survival following vertebral fractures: a population based study. Am J Epidemiol 1993; 86: 247–253

Jensen JS Bagger J . Long term social prognosis after hip fractures. Acta Orthop Scand 1982; 53: 97–101

Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. World Health Organization, 1994

Cummings SR Black DM Nevitt MC . Bone density at various sites for the prediction of hip fractures. Lancet 1993; 341: 72–75

Khaw KT Sneyd MJ Compston J . Bone density, parathyroid hormone and 25-hydroxyvitamin D concentrations in middle aged women. BMJ 1992; 305: 273–276

Hans D Dargent-Molina P Schott AM . Ultrasonographic heel measurements predict heel fracture in elderly: the EPIDOS study. Lancet 1996; 348: 511–514

Thompson PW Taylor J Fisher A . A prospective study of fracture prediction using heel ultrasound in postmenopausal women. Bone and Tooth Autumn Meeting, 1996 (Abstract)

Thompson PW . Who and how to screen? Cost Options in Osteoporosis 1996; 2: 8–9

Pridham G Grimley Evans J . Factors associated with falls in the elderly: a community study. Age Ageing 1981; 10: 141–146

Johnson CC Miller JZ Slemenda CW . Calcium supplementation and increases in bone mineral density in children. N Engl J Med 1992; 327: 82–87

Chapuy MC Arlot ME Delmas PD Menieur PJ . Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women. BMJ 1994; 308: 1081–1082

Tilyard MW Spears GFS Thomson J Dovey S . Treatment of postmenopausal osteoporosis with calcitriol or calcium. N Engl J Med 1992; 326: 357–362

Sambrook P Birmingham J Kelly P . Prevention of corticosteroid induced osteoporosis: a comparison of calcium, calcitriol and calcitonin. N Engl J Med 1993; 328: 1747–1752.

Managing Osteoporosis. Drug Ther Bull 1996; 31: 45–48

Daly E Vessey MP Hawkins MM . Risk of venous thromboembolism in users of hormone replacement therapy. Lancet 1996; 348: 977–980

Marsden J Sarks NPM . Hormone replacement therapy and breast cancer. Endocrine Related Cancer 1996; 3: 81–97

Storm T Thansborg G Steinke T . Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis. N Engl J Med 1990; 322: 1265–1271

Mulder H Struys A . Intermittent cyclical etidronate in the prevention of steroid-induced bone loss. Br J Rheumatol 1994; 33: 348–350

Liberman VA Weiss SR Broll J . Effect of oral alendronate on bone mineral density and the incidence of fracture in postmenopausal osteoporosis. N Engl J Med 1995; 333: 1437–1443

Lauritzen JB Petersen MM Lund B . Effect of external hip protectors on hip fractures. Lancet 1993; 341: 11–13

Villar MTA Thompson PW Hill P . Will elderly rest home residents wear hip protectors? Age Ageing (in press)

Vetter NJ Lewis PA Ford D . Can health workers prevent fractures in elderly people? BMJ 1992; 304: 888–890

Cooper C . The Epidemiology of Hip Fractures in the Elderly. DM thesis, University of London, 1989

Effective Health Care. Screening for osteoporosis to prevent fractures. University of Leeds, 1992

Thompson PW Taylor J Fisher A Rogers D . Heel ultrasound and fracture history in 3179 postmenopausal women. Arthritis Rheum 1995; 38: S358